全文获取类型
收费全文 | 36472篇 |
免费 | 1877篇 |
国内免费 | 181篇 |
专业分类
耳鼻咽喉 | 465篇 |
儿科学 | 720篇 |
妇产科学 | 602篇 |
基础医学 | 4816篇 |
口腔科学 | 1242篇 |
临床医学 | 2838篇 |
内科学 | 8785篇 |
皮肤病学 | 860篇 |
神经病学 | 2668篇 |
特种医学 | 1481篇 |
外科学 | 5934篇 |
综合类 | 268篇 |
一般理论 | 3篇 |
预防医学 | 1170篇 |
眼科学 | 653篇 |
药学 | 2334篇 |
中国医学 | 56篇 |
肿瘤学 | 3635篇 |
出版年
2023年 | 204篇 |
2022年 | 472篇 |
2021年 | 818篇 |
2020年 | 377篇 |
2019年 | 548篇 |
2018年 | 789篇 |
2017年 | 561篇 |
2016年 | 614篇 |
2015年 | 687篇 |
2014年 | 924篇 |
2013年 | 1046篇 |
2012年 | 1615篇 |
2011年 | 1714篇 |
2010年 | 925篇 |
2009年 | 846篇 |
2008年 | 1526篇 |
2007年 | 1560篇 |
2006年 | 1559篇 |
2005年 | 1626篇 |
2004年 | 1590篇 |
2003年 | 1468篇 |
2002年 | 1467篇 |
2001年 | 1257篇 |
2000年 | 1400篇 |
1999年 | 1223篇 |
1998年 | 429篇 |
1997年 | 309篇 |
1996年 | 320篇 |
1995年 | 292篇 |
1994年 | 259篇 |
1993年 | 238篇 |
1992年 | 814篇 |
1991年 | 769篇 |
1990年 | 690篇 |
1989年 | 704篇 |
1988年 | 688篇 |
1987年 | 667篇 |
1986年 | 675篇 |
1985年 | 595篇 |
1984年 | 434篇 |
1983年 | 356篇 |
1979年 | 344篇 |
1978年 | 234篇 |
1977年 | 204篇 |
1975年 | 204篇 |
1974年 | 227篇 |
1973年 | 211篇 |
1971年 | 211篇 |
1970年 | 207篇 |
1969年 | 225篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Toshihiro Yoshitake Akira Takeda Kensaku Ohki Yuko Inoue Takanori Yamawaki Saori Otsuka Minekatsu Akimoto Mitsuru Nemoto Yasuhito Shimakura Akio Sato 《The Journal of dermatology》2015,42(7):735-738
Finasteride is standard medical treatment for androgenetic alopecia; however, no large studies with 5 years or more of follow up have been performed in Japan. The authors followed Japanese men with androgenetic alopecia treated with finasteride for 5 years to evaluate long‐term treatment efficacy. Of 903 men treated with finasteride (1 mg/day), 801 patients were evaluated over 5 years by modified global photographic assessment. Although the proportion of improvement was high (99.4%), modified global photographic assessment scores after 5 years of treatment were lower in patients with more advanced disease as measured by the modified Norwood–Hamilton scale. After separating patients into “sufficient” and “insufficient” efficacy groups according to the modified global photographic assessment score after 5 years (scores ≥6 and <6, respectively), multivariate analysis showed that independent risk factors of insufficient efficacy were age at start of treatment of 40 years or more (P = 0.021) and classification on the modified Norwood–Hamilton scale (P < 0.001), whereas presence of stress at start of treatment was a negative predictor (P = 0.025). In conclusion, continuous finasteride treatment for 5 years improved androgenetic alopecia with sustained effect among Japanese. Younger age and less advanced disease at start of treatment were the key predictors of higher finasteride efficacy. 相似文献
4.
5.
6.
Marcelo Sato‐Sano Solange Pistori Teixeira Juliano Cordova Vargas Otvio Cesar Carvalho Guimares Baiocchi Milvia Maria Simes e Silva Enokihara Elimar Elias Gomes Mariana Dias Batista 《The Journal of dermatology》2019,46(7):618-621
Eosinophilic dermatosis of hematological malignancy is a paraneoplastic skin eruption associated with chronic lymphocytic leukemia and other B‐cell malignancies. It clinically resembles an insect bite reaction and it can precede the symptoms of the hematological malignancy or be related to a more aggressive course. Different treatments have been proposed, but partial response and recurrence are frequent. Herein, we describe a case of eosinophilic dermatosis associated with mantle cell lymphoma with remission after lenalidomide therapy. 相似文献
7.
8.
9.
10.
Kei Kamide Yoshihiro Kokubo Hironori Hanada Junko Nagura Jin Yang Shin Takiuchi Chihiro Tanaka Mariko Banno Yoshikazu Miwa Masayoshi Yoshii Tetsutaro Matayoshi Hisayo Yasuda Takeshi Horio Akira Okayama Hitonobu Tomoike Yuhei Kawano Toshiyuki Miyata 《Hypertension research》2006,29(4):243-252
Mutations in the gene encoding 11beta-hydroxysteroid dehydrogenase type 2, HSD11B2, cause a rare monogenic juvenile hypertensive syndrome called apparent mineralocorticoid excess (AME). In AME, defective HSD11B2 enzyme activity results in overstimulation of the mineralocorticoid receptor (MR) by cortisol, causing sodium retention, hypokalemia, and salt-dependent hypertension. Here, we have studied whether genetic variations in HDS11B2 are implicated in essential hypertension in Japanese hypertensives and the general population. By sequencing the entire coding region and the promoter region of HDS11B2 in 953 Japanese hypertensives, we identified five missense mutations in 11 patients (L14F, n = 5; R74H, n = 1; R147H, n = 3; T156I, n = 1; R335H, n = 1) and one novel frameshift mutation (4884Gdel, n = 1) in a heterozygous state, in addition to 19 genetic variations. All genetic variations identified were rare, with minor allele frequencies less than 0.005. Four of 12 patients with the missense/frameshift mutations showed renal failure. Four missense mutations, L14F, R74H, R147H, and R335H, were successfully genotyped in the general population, with a sample size of 3,655 individuals (2,175 normotensives and 1,480 hypertensives). Mutations L14F, R74H, R147H, and R335H were identified in hypertensives (n = 6, 8, 3, and 0, respectively) and normotensives (n = 8, 12, 5, and 0, respectively) with a similar frequency, suggesting that these missense mutations may not strongly affect the etiology of essential hypertension. Since the allele frequency of all of the genetic variations identified in this study was rare, an association study was not conducted. Taken together, our results indicate that missense mutations in HSD11B2 do not substantially contribute to essential hypertension in Japanese. 相似文献